Savior Lifetec Corporation (TPEX:4167)
18.05
-0.15 (-0.82%)
At close: Dec 5, 2025
Savior Lifetec Company Description
Savior Lifetec Corporation, a specialty injectable company, develops, produces, and supplies sterile active pharmaceutical ingredients and finished dosage formulations.
The company provides various carbapenem generic drugs and injections, such as paliperidone palmitate, cetrorelix and ganirelix acetate, plecanatide, prucalopride succinate, and brinzolamide.
It offers imipenem and cilastatin, meropenem, and ertapenem products. The company was founded in 1993 and is headquartered in Tainan, Taiwan.
Savior Lifetec Corporation
| Country | Taiwan |
| Founded | 1993 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 384 |
| CEO | Chih-Fang Chen |
Contact Details
Address: No. 1, Nanke 6th Road Tainan, 35053 Taiwan | |
| Phone | 886 6 505 1200 |
| Website | saviorlifetec.com.tw |
Stock Details
| Ticker Symbol | 4167 |
| Exchange | Taipei Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | TWD |
| ISIN Number | TW0004167002 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Chih-Fang Chen | President and Managerial Officer |
| Kuo-Wei Lin | Financial Officer and Accounting Supervisor |
| Chia-Chu Chou | Representative Director and Assistant Vice President |
| Fang Zhen Xu | Head of Internal Audit |